Skip to main content
logo
Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.650
+0.050 (1.09%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Treace Medical Concepts Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
205.31212.69209.36187.12141.8494.42
Revenue Growth
-3.95%1.59%11.88%31.92%50.22%64.59%
Gross Profit
163.12169.75168.26151.94116.3177.53
Operating Income
-53.72-54.15-55.69-51.43-34.84-16.51
Net Income
-59.52-59-55.74-49.53-42.82-20.75
Earnings Per Share
-0.93-0.93-0.90-0.81-0.77-0.43
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
45.6248.3775.68123.281.25105.83
Total Debt
73.0571.8669.6570.368.5929.54
Net Cash (Debt)
-27.43-23.56.0252.912.6676.3
Net Cash Growth
---88.61%317.71%-83.40%-
Net Cash Per Share
-0.43-0.370.100.870.231.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.58-15.97-37.17-34.58-30.65-17.19
Capital Expenditures
-10.47-13.52-11.59-11.46-14.84-2.71
Free Cash Flow
-25.05-29.49-48.76-46.03-45.49-19.9
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
79.45%79.81%80.37%81.20%82.00%82.11%
Operating Margin
-26.17%-25.46%-26.60%-27.48%-24.57%-17.49%
Pretax Margin
-28.99%-27.74%-26.63%-26.47%-30.19%-21.77%
Profit Margin
-28.99%-27.74%-26.63%-26.47%-30.19%-21.97%
FCF Margin
-12.20%-13.86%-23.29%-24.60%-32.07%-21.07%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.470.732.214.209.0010.50